Bluebird Bio

Bluebird Bio

The USA company bluebird bio has launched the primary gene medical care for the blood disease transfusion-dependent beta-thalassemia within the EU, with a hospital in Germany changing into its initial qualified treatment center. Bluebird bio’s gene medical care, branded as…